Naturewings Holidays approves FY26 results, recommends ₹1.60 dividend
Naturewings Holidays Ltd has approved its FY26 financial results and recommended a final dividend of ₹1.60 per equity share. The Board also adopted the Naturewings Holidays Limited Employee Stock Option Scheme – 2026, granting up to 200,000 options to eligible employees and directors. Shareholders will vote on these matters at the 8th AGM scheduled for August 31, 2026.

*this image is generated using AI for illustrative purposes only.
Naturewings Holidays Ltd has approved its financial results for the fiscal year ended March 31, 2026 (FY26), and recommended a final dividend of ₹1.60 per equity share. The Board of Directors also adopted the Naturewings Holidays Limited Employee Stock Option Scheme – 2026, signaling a dual focus on shareholder returns and employee retention. Shareholders will vote on the dividend and the ESOP scheme at the upcoming Annual General Meeting (AGM). This move ensures timely distribution of profits while aligning long-term employee incentives with corporate performance.
The Board meeting was held on July 27, 2026, in a hybrid mode at the company’s registered office in Kolkata. In addition to approving the Director’s Report along with its annexures, the Board convened the company’s 8th AGM for August 31, 2026, at 1 p.m. via video conferencing or other audio-visual means. The final dividend payment, subject to shareholder approval, is scheduled to be made on or before September 30, 2026. The company will disclose the record date separately in compliance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dividend and AGM Details
The recommended dividend of ₹1.60 per share applies to equity shares with a face value of ₹10 each. The payout is contingent upon approval by members at the ensuing AGM. While the record date for determining entitlement has not yet been announced, the company stated it will be disclosed separately in compliance with regulatory requirements.
| Event | Date/Detail |
|---|---|
| Board Meeting Date | July 27, 2026 |
| Recommended Final Dividend | ₹1.60 per share |
| Face Value | ₹10 |
| AGM Date | August 31, 2026 |
| Payment Deadline | On or before September 30, 2026 |
Employee Stock Option Scheme – 2026
The Board approved the adoption of the ESOP Scheme pursuant to Section 62(1)(b) of the Companies Act, 2013, Rule 12 of the Companies (Share Capital and Debentures) Rules, 2014, and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The scheme proposes to grant up to 200,000 stock options, convertible into an equivalent number of equity shares.
Eligible participants include permanent employees and directors, excluding independent directors, as determined by the Nomination and Remuneration Committee. Key terms of the scheme include:
- Vesting Period: Minimum one year from the date of grant.
- Exercise Price: Determined by the Nomination and Remuneration Committee in accordance with applicable laws.
- Approval Requirement: The scheme requires shareholder approval via a Special Resolution.
The detailed terms and conditions will be placed before shareholders for approval at the AGM. The exercise period and maximum number of options per employee will be specified in the scheme documents after vesting.
What the Numbers Show
The recommendation of a final dividend alongside the launch of a new ESOP scheme highlights Naturewings Holidays’ strategy to balance immediate shareholder returns with long-term talent incentivization. By capping the ESOP pool at 200,000 options, the company aims to align employee interests with corporate performance while managing potential dilution. The compressed timeline between the board meeting and the AGM suggests an efficient governance process, ensuring timely communication of FY26 outcomes to investors.
Historical Stock Returns for Naturewings Holidays
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +2.77% | -12.00% | -15.13% | -13.83% | -21.99% |
How might the introduction of the 200,000-share ESOP pool impact existing shareholder equity and potential future dilution?
What specific performance metrics or KPIs will the Nomination and Remuneration Committee use to determine the exercise price for the new ESOP scheme?
Given the compressed timeline between the board meeting and the AGM, are there any indications of urgent strategic shifts or governance pressures driving this schedule?
































